TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.880
-0.120 (-2.40%)
At close: Jul 11, 2025, 4:00 PM
4.890
+0.010 (0.20%)
After-hours: Jul 11, 2025, 4:04 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $185.03 million as of July 11, 2025. Its market cap has increased by 22.31% in one year.
Market Cap
185.03M
Enterprise Value
205.15M
1-Year Change
22.31%
Ranking
Category
Stock Price
$4.88
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $185.03M, a decrease of -43.72%. That is a compound annual growth rate of -12.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 185.03M | 21.12% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |